Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,21M | -0,40% |
| 2026-05-18 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 4,86M | Derivative Exercise and Sale | 33,27 - 37,99 | 3,62M | - |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,36M | -0,40% |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,36M | -0,40% |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 3,57M | Derivative Exercise and Sale | 25,00 - 25,41 | 3,62M | - |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,50M | -0,40% |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,50M | -0,40% |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 4,00M | Derivative Exercise and Sale | 27,74 - 29,51 | 3,62M | - |
| 2026-04-15 | Mr. Peter McGrathSenior VP & CFO | -24,55k | 579,67k | Verkauf | 23,61 | 113,47k | -17,79% |
| 2026-04-15 | Ms. Anna Chiara JonesSenior VP, General Counsel & Corporate Secretary | -4,91k | 115,94k | Verkauf | 23,61 | 56,35k | -8,02% |
| 2026-04-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -13,75k | 324,63k | Verkauf | 23,61 | 398,19k | -3,34% |
| 2026-04-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -8,45k | 199,42k | Verkauf | 23,61 | 69,31k | -10,86% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,64M | -0,40% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,64M | -0,40% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 3,29M | Derivative Exercise and Sale | 23,03 - 23,65 | 3,62M | - |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 0,00 | Sale to Issuer | - | 35,78M | -0,79% |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 0,00 | Other Disposition | - | 35,78M | -0,79% |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 5,33M | Derivative Exercise and Sale | 17,80 - 20,34 | 3,62M | - |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 2,63M | Derivative Exercise and Sale | 16,93 - 18,81 | 56,26k | - |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 0,00 | Sale to Issuer | - | 8,87M | -1,66% |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 0,00 | Other Disposition | - | 8,87M | -1,66% |
| 2026-02-11 | Mr. Peter McGrathSenior VP & CFO | -25,54k | 445,33k | Verkauf | 17,44 | 75,52k | -25,27% |
| 2026-02-11 | Ms. Anna Chiara JonesSenior VP, General Counsel & Corporate Secretary | -16,78k | 292,56k | Verkauf | 17,44 | 48,76k | -25,60% |
| 2026-02-13 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -86,80k | 1,39M | Verkauf | 16,01 | 376,94k | -18,72% |
| 2026-02-11 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -23,23k | 404,97k | Verkauf | 17,44 | 56,26k | -29,22% |
| 2026-02-11 | Mr. Steven VonturCAO & Controller | -4,34k | 75,72k | Verkauf | 17,44 | 36,57k | -10,61% |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 0,00 | Other Disposition | - | 12,34M | -3,80% |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 9,78M | Derivative Exercise and Sale | 20,03 - 20,06 | 241,18k | - |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 0,00 | Sale to Issuer | - | 12,34M | -3,80% |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 3,90M | Derivative Exercise and Sale | 20,04 - 20,06 | 0,00 | - |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 0,00 | Other Disposition | - | 9,02M | -2,11% |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 0,00 | Sale to Issuer | - | 9,02M | -2,11% |
| 2026-01-08 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -12,67k | 253,42k | Derivative Exercise and Sale | 20,00 | 241,18k | - |
| 2026-01-08 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -12,67k | 0,00 | Sale to Issuer | - | 12,83M | -0,10% |
| 2026-01-08 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -5,66k | 113,22k | Derivative Exercise and Sale | 20,00 | 0,00 | - |
| 2026-01-08 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -5,66k | 0,00 | Sale to Issuer | - | 9,21M | -0,06% |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 9,04M | Derivative Exercise and Sale | 18,04 - 18,08 | 241,18k | - |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 0,00 | Other Disposition | - | 12,84M | -3,75% |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 0,00 | Sale to Issuer | - | 12,84M | -3,75% |
| 2025-12-19 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -2,00M | 31,51M | Derivative Exercise and Sale | 15,01 - 16,71 | 241,18k | - |
| 2025-12-19 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -2,00M | 0,00 | Sale to Issuer | - | 13,34M | -13,04% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | 242,94k | 0,00 | Derivative Exercise and Retained Stock | - | 0,00 | -100,00% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -350,00k | 5,34M | Automatic Disposition | 12,06 - 16,04 | 0,00 | -100,00% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -242,94k | 0,00 | Sale to Issuer | - | 9,22M | -2,57% |
| 2025-12-09 | Dr. Kamal GhaffarianCo-Founder & Chairman | -28,14k | 0,00 | Other Disposition | - | 36,07M | -0,08% |
| 2025-12-09 | Dr. Kamal GhaffarianCo-Founder & Chairman | -28,14k | 0,00 | Other Disposition | - | 36,07M | -0,08% |
| 2025-11-15 | Mr. Steven VonturCAO & Controller | -1,34k | 12,76k | Sale to Issuer | 9,53 | 25,02k | -5,08% |
| 2025-11-12 | Mr. Michael BlitzerIndependent Director | 241,08k | 2,19M | Kauf | 8,83 - 9,27 | 1,87M | 14,82% |
| 2025-08-24 | Mr. Steven VonturCAO & Controller | -1,83k | 16,38k | Sale to Issuer | 8,97 | 21,36k | -7,88% |
| 2025-07-28 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 542,97k | Derivative Exercise and Sale | 13,49 | 3,62M | - |
| 2025-07-28 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 36,09M | -0,11% |
| 2025-07-17 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 483,87k | Derivative Exercise and Sale | 12,02 | 3,62M | - |
| 2025-07-17 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 36,13M | -0,11% |
| 2025-07-11 | Dr. Kamal GhaffarianCo-Founder & Chairman | -80,51k | 970,07k | Derivative Exercise and Sale | 12,05 | 3,62M | - |
| 2025-07-11 | Dr. Kamal GhaffarianCo-Founder & Chairman | -80,51k | 0,00 | Sale to Issuer | - | 36,17M | -0,22% |
| 2025-06-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 38,74M | -0,10% |
| 2025-06-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 484,82k | Derivative Exercise and Sale | 12,04 | 3,62M | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
